Overview
Status
Active
Registry date
2024-10-03
Share capital
5,000.00 PLN
Registered address
Aleje Ujazdowskie 41, 00-540 Warszawa, Poland
Email
Financials
From the notes
| Current income tax (CIT due) | $237 |
Filing timeliness
1 of 1 financial statements was filed late (for 2025, 34 days late).
- 202518/08/2026
Filed on timeDelayFiling deadline
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.
Results vs industry
Revenue
This companyUSD 20.55kMedianUSD 818.63kAverageUSD 7.98m
Net profit
This companyUSD 411.10MedianUSD 20.51kAverageUSD 554.06k
Operating costs
This companyUSD 19.51kMedianUSD 642.78kAverageUSD 7.07m
Assets
This companyUSD 19.85kMedianUSD 826.85kAverageUSD 6.62m
Industry
Public procurement
No recorded participation in tenders.
R-Biopharm Poland is the contractor in one public sector contract, worth USD 2.46k.
| Signed on | Subject | Amount | Public buyer | |
|---|---|---|---|---|
| Jul 15, 2026 | Purchase of enzyme tests | $2,465 | Szkoła Główna Gospodarstwa Wiejskiego w Warszawie |
Authorized Representatives
Christian Moraeno Dreher – Management Board Member
Manner of representation
Each member of the management board independently
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
R-biopharm Ag | 100 | $1,350.62 | 100% |
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2024-10-10.
75 1090 2398 0000 0001 5948 9997
Debt
No entries in the National Debtors Register (KRZ).
Public aid
No public aid cases recorded in the last 10 years.
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Metrum CryoflexS.A. | $13,795,733.67 | metrum.com.pl | ||
| SigvarisS.A. | $11,438,802.73 | sigvaris.com | ||
| Ziółkowski JuventasS.K.A. | $2,900,579.48 | juventas.pl | ||
| WS Tech Lorenssp. j. | $2,722,397.69 | wstech.eu | ||
| Si-Curasp. z o.o. | $1,631,852.12 | si-cura.pl | ||
| AmbioP.S.A. | $1,357,457.41 | ambio.com.pl | ||
| Stethomesp. z o.o. | $267,112.27 | stethome.com | ||
| ChitomedP.S.A. | $206,587.41 | chitomed.com | ||
| Orto Novasp. z o.o. | $158,631.83 | zarychta.com.pl | ||
| ClebreS.A. | $87,678.59 | clebre.com |
Change history
| Date | Event | |
|---|---|---|
| 2025-05-12 | Name change (Senieta → R-Biopharm Poland) | |
| 2025-05-12 | Switch to PKD 2025 (9 PKD 2007 codes → 9 PKD 2025 codes) | |
| 2024-10-03 | Entered in the register |
FAQ
The main business activity of R-Biopharm Poland focuses on manufacture of other medical instruments and supplies.
The company was registered in the Polish National Court Register (KRS) on October 3, 2024.
The headquarters is located at: Aleje Ujazdowskie 41, 00-540 Warszawa.
The management board consists of: Christian Moraeno Dreher (Member of the Management Board).
The share capital of the company is PLN 5,000 (approx. $1,351).
The latest available financial statement covers the period from September 2, 2024 to December 31, 2025.
In 2025, the company's revenue reached USD 20,547.
Yes, in 2025 the company was profitable, achieving a net profit of USD 411.
The largest operating cost category falls under employee remuneration. This category amounted to USD 11,828 in 2025, representing 61% of all operating expenses.
Last updated: 2026-10-07